 | • レポートコード：MRC2Q12-16816 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、市販吐き気止め薬のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 市販吐き気止め薬のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 市販吐き気止め薬の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 市販吐き気止め薬のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの市販吐き気止め薬の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の市販吐き気止め薬の売上および2028年までの予測に焦点を当てています。 市販吐き気止め薬のグローバル主要企業には、Church & Dwight、Prestige Consumer Healthcare、Procter & Gamble、Kramer Laboratories、WellSpring Pharmaceutical Corporation、Alva-Amco、Boiron、Guangzhou Baiyunshan Pharmaceutical、Taisho Pharmaceutical、SSP CO.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 市販吐き気止め薬市場は、タイプとアプリケーションによって区分されます。世界の市販吐き気止め薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 液体、錠剤 【アプリケーション別セグメント】 オンライン販売、オフライン販売 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 市販吐き気止め薬製品概要 - タイプ別市場（液体、錠剤） - アプリケーション別市場（オンライン販売、オフライン販売） - 調査の目的 ・エグゼクティブサマリー - 世界の市販吐き気止め薬販売量予測2017-2028 - 世界の市販吐き気止め薬売上予測2017-2028 - 市販吐き気止め薬の地域別販売量 - 市販吐き気止め薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別市販吐き気止め薬販売量 - 主要メーカー別市販吐き気止め薬売上 - 主要メーカー別市販吐き気止め薬価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（液体、錠剤） - 市販吐き気止め薬のタイプ別販売量 - 市販吐き気止め薬のタイプ別売上 - 市販吐き気止め薬のタイプ別価格 ・アプリケーション別市場規模（オンライン販売、オフライン販売） - 市販吐き気止め薬のアプリケーション別販売量 - 市販吐き気止め薬のアプリケーション別売上 - 市販吐き気止め薬のアプリケーション別価格 ・北米市場 - 北米の市販吐き気止め薬市場規模（タイプ別、アプリケーション別） - 主要国別の市販吐き気止め薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの市販吐き気止め薬市場規模（タイプ別、アプリケーション別） - 主要国別の市販吐き気止め薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の市販吐き気止め薬市場規模（タイプ別、アプリケーション別） - 主要国別の市販吐き気止め薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の市販吐き気止め薬市場規模（タイプ別、アプリケーション別） - 主要国別の市販吐き気止め薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの市販吐き気止め薬市場規模（タイプ別、アプリケーション別） - 主要国別の市販吐き気止め薬市場規模（トルコ、サウジアラビア） ・企業情報 Church & Dwight、Prestige Consumer Healthcare、Procter & Gamble、Kramer Laboratories、WellSpring Pharmaceutical Corporation、Alva-Amco、Boiron、Guangzhou Baiyunshan Pharmaceutical、Taisho Pharmaceutical、SSP CO. ・産業チェーン及び販売チャネル分析 - 市販吐き気止め薬の産業チェーン分析 - 市販吐き気止め薬の原材料 - 市販吐き気止め薬の生産プロセス - 市販吐き気止め薬の販売及びマーケティング - 市販吐き気止め薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 市販吐き気止め薬の産業動向 - 市販吐き気止め薬のマーケットドライバー - 市販吐き気止め薬の課題 - 市販吐き気止め薬の阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global OTC Anti-nausea Drugs Market
The global OTC Anti-nausea Drugs market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Liquid accounting for % of the OTC Anti-nausea Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Online Sales segment is altered to an % CAGR throughout this forecast period.
China OTC Anti-nausea Drugs market size is valued at US$ million in 2021, while the North America and Europe OTC Anti-nausea Drugs are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe OTC Anti-nausea Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global OTC Anti-nausea Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global OTC Anti-nausea Drugs market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global OTC Anti-nausea Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global OTC Anti-nausea Drugs market.
Global OTC Anti-nausea Drugs Scope and Market Size
OTC Anti-nausea Drugs market is segmented by players, region (country), by Type and by Sales Channel. Players, stakeholders, and other participants in the global OTC Anti-nausea Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Sales Channel for the period 2017-2028.
Segment by Type
Liquid
Tablet
Segment by Sales Channel
Online Sales
Offline Sales
By Company
Church & Dwight
Prestige Consumer Healthcare
Procter & Gamble
Kramer Laboratories
WellSpring Pharmaceutical Corporation
Alva-Amco
Boiron
Guangzhou Baiyunshan Pharmaceutical
Taisho Pharmaceutical
SSP CO.
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Anti-nausea Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Liquid
1.2.3 Tablet
1.3 Market by Sales Channel
1.3.1 Global OTC Anti-nausea Drugs Market Size Growth Rate by Sales Channel, 2017 VS 2021 VS 2028
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global OTC Anti-nausea Drugs Market Perspective (2017-2028)
2.2 OTC Anti-nausea Drugs Growth Trends by Region
2.2.1 OTC Anti-nausea Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 OTC Anti-nausea Drugs Historic Market Size by Region (2017-2022)
2.2.3 OTC Anti-nausea Drugs Forecasted Market Size by Region (2023-2028)
2.3 OTC Anti-nausea Drugs Market Dynamics
2.3.1 OTC Anti-nausea Drugs Industry Trends
2.3.2 OTC Anti-nausea Drugs Market Drivers
2.3.3 OTC Anti-nausea Drugs Market Challenges
2.3.4 OTC Anti-nausea Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top OTC Anti-nausea Drugs Players by Revenue
3.1.1 Global Top OTC Anti-nausea Drugs Players by Revenue (2017-2022)
3.1.2 Global OTC Anti-nausea Drugs Revenue Market Share by Players (2017-2022)
3.2 Global OTC Anti-nausea Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by OTC Anti-nausea Drugs Revenue
3.4 Global OTC Anti-nausea Drugs Market Concentration Ratio
3.4.1 Global OTC Anti-nausea Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Anti-nausea Drugs Revenue in 2021
3.5 OTC Anti-nausea Drugs Key Players Head office and Area Served
3.6 Key Players OTC Anti-nausea Drugs Product Solution and Service
3.7 Date of Enter into OTC Anti-nausea Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Anti-nausea Drugs Breakdown Data by Type
4.1 Global OTC Anti-nausea Drugs Historic Market Size by Type (2017-2022)
4.2 Global OTC Anti-nausea Drugs Forecasted Market Size by Type (2023-2028)
5 OTC Anti-nausea Drugs Breakdown Data by Sales Channel
5.1 Global OTC Anti-nausea Drugs Historic Market Size by Sales Channel (2017-2022)
5.2 Global OTC Anti-nausea Drugs Forecasted Market Size by Sales Channel (2023-2028)
6 North America
6.1 North America OTC Anti-nausea Drugs Market Size (2017-2028)
6.2 North America OTC Anti-nausea Drugs Market Size by Type
6.2.1 North America OTC Anti-nausea Drugs Market Size by Type (2017-2022)
6.2.2 North America OTC Anti-nausea Drugs Market Size by Type (2023-2028)
6.2.3 North America OTC Anti-nausea Drugs Market Share by Type (2017-2028)
6.3 North America OTC Anti-nausea Drugs Market Size by Sales Channel
6.3.1 North America OTC Anti-nausea Drugs Market Size by Sales Channel (2017-2022)
6.3.2 North America OTC Anti-nausea Drugs Market Size by Sales Channel (2023-2028)
6.3.3 North America OTC Anti-nausea Drugs Market Share by Sales Channel (2017-2028)
6.4 North America OTC Anti-nausea Drugs Market Size by Country
6.4.1 North America OTC Anti-nausea Drugs Market Size by Country (2017-2022)
6.4.2 North America OTC Anti-nausea Drugs Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe OTC Anti-nausea Drugs Market Size (2017-2028)
7.2 Europe OTC Anti-nausea Drugs Market Size by Type
7.2.1 Europe OTC Anti-nausea Drugs Market Size by Type (2017-2022)
7.2.2 Europe OTC Anti-nausea Drugs Market Size by Type (2023-2028)
7.2.3 Europe OTC Anti-nausea Drugs Market Share by Type (2017-2028)
7.3 Europe OTC Anti-nausea Drugs Market Size by Sales Channel
7.3.1 Europe OTC Anti-nausea Drugs Market Size by Sales Channel (2017-2022)
7.3.2 Europe OTC Anti-nausea Drugs Market Size by Sales Channel (2023-2028)
7.3.3 Europe OTC Anti-nausea Drugs Market Share by Sales Channel (2017-2028)
7.4 Europe OTC Anti-nausea Drugs Market Size by Country
7.4.1 Europe OTC Anti-nausea Drugs Market Size by Country (2017-2022)
7.4.2 Europe OTC Anti-nausea Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OTC Anti-nausea Drugs Market Size (2017-2028)
8.2 Asia-Pacific OTC Anti-nausea Drugs Market Size by Type
8.2.1 Asia-Pacific OTC Anti-nausea Drugs Market Size by Type (2017-2022)
8.2.2 Asia-Pacific OTC Anti-nausea Drugs Market Size by Type (2023-2028)
8.2.3 Asia-Pacific OTC Anti-nausea Drugs Market Share by Type (2017-2028)
8.3 Asia-Pacific OTC Anti-nausea Drugs Market Size by Sales Channel
8.3.1 Asia-Pacific OTC Anti-nausea Drugs Market Size by Sales Channel (2017-2022)
8.3.2 Asia-Pacific OTC Anti-nausea Drugs Market Size by Sales Channel (2023-2028)
8.3.3 Asia-Pacific OTC Anti-nausea Drugs Market Share by Sales Channel (2017-2028)
8.4 Asia-Pacific OTC Anti-nausea Drugs Market Size by Region
8.4.1 Asia-Pacific OTC Anti-nausea Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific OTC Anti-nausea Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America OTC Anti-nausea Drugs Market Size (2017-2028)
9.2 Latin America OTC Anti-nausea Drugs Market Size by Type
9.2.1 Latin America OTC Anti-nausea Drugs Market Size by Type (2017-2022)
9.2.2 Latin America OTC Anti-nausea Drugs Market Size by Type (2023-2028)
9.2.3 Latin America OTC Anti-nausea Drugs Market Share by Type (2017-2028)
9.3 Latin America OTC Anti-nausea Drugs Market Size by Sales Channel
9.3.1 Latin America OTC Anti-nausea Drugs Market Size by Sales Channel (2017-2022)
9.3.2 Latin America OTC Anti-nausea Drugs Market Size by Sales Channel (2023-2028)
9.3.3 Latin America OTC Anti-nausea Drugs Market Share by Sales Channel (2017-2028)
9.4 Latin America OTC Anti-nausea Drugs Market Size by Country
9.4.1 Latin America OTC Anti-nausea Drugs Market Size by Country (2017-2022)
9.4.2 Latin America OTC Anti-nausea Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OTC Anti-nausea Drugs Market Size (2017-2028)
10.2 Middle East & Africa OTC Anti-nausea Drugs Market Size by Type
10.2.1 Middle East & Africa OTC Anti-nausea Drugs Market Size by Type (2017-2022)
10.2.2 Middle East & Africa OTC Anti-nausea Drugs Market Size by Type (2023-2028)
10.2.3 Middle East & Africa OTC Anti-nausea Drugs Market Share by Type (2017-2028)
10.3 Middle East & Africa OTC Anti-nausea Drugs Market Size by Sales Channel
10.3.1 Middle East & Africa OTC Anti-nausea Drugs Market Size by Sales Channel (2017-2022)
10.3.2 Middle East & Africa OTC Anti-nausea Drugs Market Size by Sales Channel (2023-2028)
10.3.3 Middle East & Africa OTC Anti-nausea Drugs Market Share by Sales Channel (2017-2028)
10.4 Middle East & Africa OTC Anti-nausea Drugs Market Size by Country
10.4.1 Middle East & Africa OTC Anti-nausea Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa OTC Anti-nausea Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Church & Dwight
11.1.1 Church & Dwight Company Details
11.1.2 Church & Dwight Business Overview
11.1.3 Church & Dwight OTC Anti-nausea Drugs Introduction
11.1.4 Church & Dwight Revenue in OTC Anti-nausea Drugs Business (2017-2022)
11.1.5 Church & Dwight Recent Developments
11.2 Prestige Consumer Healthcare
11.2.1 Prestige Consumer Healthcare Company Details
11.2.2 Prestige Consumer Healthcare Business Overview
11.2.3 Prestige Consumer Healthcare OTC Anti-nausea Drugs Introduction
11.2.4 Prestige Consumer Healthcare Revenue in OTC Anti-nausea Drugs Business (2017-2022)
11.2.5 Prestige Consumer Healthcare Recent Developments
11.3 Procter & Gamble
11.3.1 Procter & Gamble Company Details
11.3.2 Procter & Gamble Business Overview
11.3.3 Procter & Gamble OTC Anti-nausea Drugs Introduction
11.3.4 Procter & Gamble Revenue in OTC Anti-nausea Drugs Business (2017-2022)
11.3.5 Procter & Gamble Recent Developments
11.4 Kramer Laboratories
11.4.1 Kramer Laboratories Company Details
11.4.2 Kramer Laboratories Business Overview
11.4.3 Kramer Laboratories OTC Anti-nausea Drugs Introduction
11.4.4 Kramer Laboratories Revenue in OTC Anti-nausea Drugs Business (2017-2022)
11.4.5 Kramer Laboratories Recent Developments
11.5 WellSpring Pharmaceutical Corporation
11.5.1 WellSpring Pharmaceutical Corporation Company Details
11.5.2 WellSpring Pharmaceutical Corporation Business Overview
11.5.3 WellSpring Pharmaceutical Corporation OTC Anti-nausea Drugs Introduction
11.5.4 WellSpring Pharmaceutical Corporation Revenue in OTC Anti-nausea Drugs Business (2017-2022)
11.5.5 WellSpring Pharmaceutical Corporation Recent Developments
11.6 Alva-Amco
11.6.1 Alva-Amco Company Details
11.6.2 Alva-Amco Business Overview
11.6.3 Alva-Amco OTC Anti-nausea Drugs Introduction
11.6.4 Alva-Amco Revenue in OTC Anti-nausea Drugs Business (2017-2022)
11.6.5 Alva-Amco Recent Developments
11.7 Boiron
11.7.1 Boiron Company Details
11.7.2 Boiron Business Overview
11.7.3 Boiron OTC Anti-nausea Drugs Introduction
11.7.4 Boiron Revenue in OTC Anti-nausea Drugs Business (2017-2022)
11.7.5 Boiron Recent Developments
11.8 Guangzhou Baiyunshan Pharmaceutical
11.8.1 Guangzhou Baiyunshan Pharmaceutical Company Details
11.8.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
11.8.3 Guangzhou Baiyunshan Pharmaceutical OTC Anti-nausea Drugs Introduction
11.8.4 Guangzhou Baiyunshan Pharmaceutical Revenue in OTC Anti-nausea Drugs Business (2017-2022)
11.8.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments
11.9 Taisho Pharmaceutical
11.9.1 Taisho Pharmaceutical Company Details
11.9.2 Taisho Pharmaceutical Business Overview
11.9.3 Taisho Pharmaceutical OTC Anti-nausea Drugs Introduction
11.9.4 Taisho Pharmaceutical Revenue in OTC Anti-nausea Drugs Business (2017-2022)
11.9.5 Taisho Pharmaceutical Recent Developments
11.10 SSP CO.
11.10.1 SSP CO. Company Details
11.10.2 SSP CO. Business Overview
11.10.3 SSP CO. OTC Anti-nausea Drugs Introduction
11.10.4 SSP CO. Revenue in OTC Anti-nausea Drugs Business (2017-2022)
11.10.5 SSP CO. Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer